Litron Laboratories specializes in advanced flow cytometry technologies to assess DNA damage and gene mutations, primarily in the context of toxicology testing. Their flagship products include the MicroFlow® kits, which enable the measurement of micronuclei in red blood cells, a key indicator of chromosomal damage. These kits are designed for both in vivo and in vitro applications, allowing researchers to evaluate the effects of various compounds on DNA integrity. The use of flow cytometry facilitates rapid and reproducible results, making it a gold standard method in the industry. Litron's commitment to quality is evident in their provision of calibration standards and technical support, ensuring that clients can confidently conduct their studies.

In addition to micronucleus analysis, Litron offers a range of services for gene mutation assessment, including the MutaFlow technology, which focuses on detecting gene mutations through flow cytometry. Their methodologies are validated and accepted by regulatory agencies, allowing for compliance with Good Laboratory Practice (GLP) standards. Litron's research extends to various applications, including studies on the genotoxicity of substances like cell phone radiofrequency and the effects of herbal extracts. The company actively collaborates with global experts and publishes findings in peer-reviewed journals, contributing to the advancement of toxicology and human health protection.

United States

Litron has spent the last 40 years providing critical data to pharmaceutical, medical device, government and contract research organizations around the world. With a laser focus on DNA damage and other toxic effects, we develop state-of-the-art flow cytometric methods to solve challenging problems for the toxicology industry.

Litron Laboratories

Company Details